Table II.
Reasons for discontinuation of treatment.
Reason treatment terminated | No. of patients | % |
---|---|---|
Completed treatment | 52 | 63.4% |
Adverse event | 10 | 12.2% |
Catheter problems | 10 | 12.2% |
Patient withdrawal | 6 | 7.3% |
HAMA/HARA positive | 2 | 2.4% |
Disease progression | 1 | 1.2% |
Study closure | 1 | 1.2% |
HAMA/HARA, human anti-mouse antibody/human anti-ricin antibody.